# Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

> **NCT04371185** · PHASE1 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 270 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** BAT2206
- **DRUG:** Stelara(US-licensed)
- **DRUG:** Stelara(EU-licensed)

## Key facts

- **NCT ID:** NCT04371185
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-08
- **Primary completion:** 2021-04-19
- **Final completion:** 2021-04-19
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04371185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04371185, "Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04371185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*